Serological Screening of Newborns for -Specific IgA and IgM Antibodies in Peripheral Blood Collected on Filter-Papers.

UNLABELLED

The strategic approach for preventing congenital toxoplasmosis is strictly related to the incidence of primary infection during pregnancy in a studied population. Early postnatal diagnosis by mass testing of newborns is an option in areas where obligatory serological screening in pregnant women has not been implemented but it requires sensitive immunodiagnostic methods followed by a good confirmatory analysis. The aims of the regional neonatal screening programme were (i) analysis of the prevalence of congenital infection at birth in the West Poland Province, (ii) determination of the value of the serological examination of filter-paper blood specimens collected at birth for the diagnosis of congenital toxoplasmosis, and (iii) evaluation of the duration of -specific immunoglobulin A and immunoglobulin M antibodies in infants' sera. The neonates born in the obstetric clinics of the University Gynaecology-Obstetrics Hospital in Poznan (Poland) and in the maternity wards of the 10 main district hospitals from the West Poland region were systematically screened for congenital infection. Peripheral blood from newborns was collected by a non-invasive heel-stick puncture during the first 3 days of life, absorbed onto Guthrie cards and analysed for anti- specific IgM (1996-1998) or both IgA and IgM antibodies (1998-2000) by non-commercial immunocapture ELISAs. When the screening result was positive, the diagnosis of congenital infection was confirmed by testing serum samples from the suspected neonate and the mother using a Western blot IgM-IgG comparative immunological profile analysis and traditional serological techniques (ELISA, ISAGA) for anti- IgA, IgM and IgG specific antibodies. From June 1996 to April 2000, 45,169 filter-paper specimens from liveborn neonates were screened: 27,516 samples were tested for specific IgM and the next 17,653 Guthrie cards were analysed by the combined IgA/IgM assay. The prevalence of anti- IgM in filter-paper eluates at birth was 1 per 2,117 liveborn neonates (0.47/1000) or 1 per 1,185 infants (0.84/1000) born to seronegative women with a potential risk of primary infection during pregnancy. For the joint detection of IgA and IgM, these values significantly increased to 1 per 929 neonates (1.08/1000) or 1 per 520 pregnancies at risk (1.92/1000) respectively, comparing to the seropositivity rate of 43.7% in a pregnant women population in the studied area. In newborns untreated prenatally, the diagnostic sensitivity of the IgM ELISA using neonatal Guthrie cards was not more than 86.7% and that of the combined IgA/IgM ELISA was 95%; the diagnostic specificity of the both methods was calculated to be 99.9%. Congenital infection was finally diagnosed in 35 neonates, mostly asymptomatic at birth.

CONCLUSIONS

(i) The neonatal screening for anti- IgA and/or IgM antibodies is a good sensitivity method for an early postnatal diagnosis of congenital toxoplasmosis in newborns untreated prenatally. (ii) In the absence of obligatory nation-wide screening during pregnancy followed by an early prenatal treatment, this valuable technique may be considered a preventive option in areas of a high annual number of births associated with a high seroprevalence of infection.